chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient states rash and itching started 4 hours after receiving FluLaval. Itching on wrists and left ankle. Patient applied calamine lotion to itching with temporary relief. Patient came to health center for treatment 2 days later. She was given chlorpheniramine maleate 4 mg #20 to take one time qid prn po.
First dose 2/12/2021  84-year-old male seen in office 9/7/2021 for clearance for upcomming knee surgery.  presents to the emergency department complaining of shortness of breath yesterday morning.  He began having congestion and cough with sputum production approximately 1 week ago with increasing dyspnea and chest pressure. CTA of the chest completed which demonstrated ground-glass opacities was a continuation most pronounced in the left lower lobe likely due atelectasis or air trapping tested positive for COVID-19. Tested positive for COVID-19 three weeks ago but was vaccinated with the second dose in April of 2021.
Increased yawn reflex to find air.; Chills immediately after/ cold body; Sweaty hands; Tight throat muscles; Sore upper left arm; Weird feeling in the body; Very slight difficulty breathing; Very slight difficulty articulating some words; Nausea; Difficulty sleeping; Loss of appetite; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EK8727) via an unspecified route of administration in the left arm on 24Mar2021 at 16:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety. The patient had known allergies to penicillin and amoxicillin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included omeprazole (MANUFACTURER UNKNOWN) 20mg once a day for unknown indication and from an unknown date. On 24Mar2021 at 16:45, the patient experienced increased yawn reflex to find air, chills immediately after / cold body, sweaty hands, fatigue, tight throat muscles, sore upper left arm, weird feeling in the body, very slight difficulty breathing (but SPO2 ok at 98%), very slight difficulty articulating some words, nausea, difficulty sleeping and loss of appetite. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient underwent lab tests which included oxygen saturation test on an unknown date and the result was SPO2 at 98%. The clinical outcome of events increased yawn reflex to find air, chills immediately after / cold body, sweaty hands, fatigue, tight throat muscles, sore upper left arm, weird feeling in the body, very slight difficulty breathing, very slight difficulty articulating some words, nausea, difficulty sleeping and loss of appetite was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Extreme fatigue; Headache; Trouble breathing through mask; Sore throat; Feeling warm; Soreness at the injection site; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 41-year-old male patient received first dose of bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection, Batch/Lot Number: EN6205) via an unspecified route of administration, administered in arm right on 07Mar2021 17:45 (at the age of 41-year-old) at dose 1, single for covid-19 immunisation. Medical history was reported as yes and included covid-19 (If covid prior vaccination: Yes). Patient had no known allergies. Concomitant medications were not reported. Other medications in two weeks were reported as yes and patient did not have other vaccine in four weeks. Patient was not tested for covid post vaccination. On 08Mar2021 07:00 the patient experienced extreme fatigue, headache, trouble breathing through mask, sore throat. feeling warm. soreness at the injection site. Patient did not receive treatment for the adverse events. Outcome of the events was not resolved.  No follow-up attempts are possible. No further information is expected.
Patient c/o dizziness and feeling lightheaded. Vitals were stable at 10:33 and 10:37. Patient refused wheelchair and demanded to leave after second set of vitals were taken.
Per patient report symptoms include pain to injection site occurred immediately and continue without improvement. Dull ache to right shoulder (deltoid area) is rated 2-3/10 with pressure. Pt is able to have the pain relieved at 0/10 with use of TYLENOL 500 mg 2 tab po PRN. Pt reports pain has not lessened.
Pt had vaccine 10/31/18 on 11/01/18 seen at office for c/o redness, warmth, tender to touch at injection site, had not taken anything for reaction or pain per pt.  Area measures 2.5 cm x 1.25 cm slight raised patch of erythema.  Instructed to use ice on the area, can take Benadryl and should call if noting any worsening ssx.
Sore shoulder, nausea, diarrhea, joint pain, muscle pain, headache
Severe itching started at approx 3:45 PM on 11-2-09, unable to sleep, call work at 2 AM 11-3-09 to inform. Called ER was told to take BENADRYL, going to call primary physician for appt.
Fever; This is a spontaneous report from a contactable physician received via Pfizer sales representative. A 1-year-old-female patient received pneumococcal 13-valent conjugate vaccine (dipht crm197 protein) (PREVNAR 13), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced fever on an unspecified date which was further reported that when her daughter was a baby she would experience a fever after getting her Prevnar 13 doses. The outcome of the event was unknown.   No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
11/28/99 pm developed painful, sore deltoid at injection site. Redness, swelling and generalized rash as well. Seen by MD 11/29 am/local site reaction 3x4cm very red, bright & urticarial generalized rash, face, arms, legs, trunk.
Shingrix reconstituted with other diluent.; Shingrix reconstituted with other diluent.; This case was reported by a nurse via call center representative and described the occurrence of wrong solution used in drug reconstitution in a patient who received Herpes zoster (Shingrix) (batch number 4G94Z, expiry date 3rd February 2023) for prophylaxis.   In October 2021, the patient received Shingrix. In October 2021, unknown after receiving Shingrix, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that the patient received Shingrix on 22nd October 2021 or 29th October 2021, with the powder component of Shingrix reconstituted with other diluent, which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. The reporter did not want to provide patients demographic data. The reporter consented to follow up. This case was one of the 8 cases reported by the same reporter.
Pt recvd 1st dose Hep B vax 22FEB91 & subsequent to vax pt noted to be pregnant; pt recvd meds for flu-like sx; 25APR91 exp small amount of vaginal bleeding & low abd pain; 26APR91 sonogram revealed fetal demise; 27APR91 to ER some clotting
pt hospitalized from 1/8/22 - 1/13/22 with severe HTN and developing NSTEMI; c/o severe weakness and diarrhea x 1 wk; found to be positive for COVID; no respiratory distress; elevated troponin; DNR/DNI; steroids and ABX given; dc'd to nursing home, where she later passed away
Vaccine given 3/19/09, fever developed 3/27/09.  Rash erythematous macular papule with palms/soles & buccal urticaria developed 3/29.  Looks like measles.
Patient fully vaccinated (Moderna), but not boosted, admitted to the hospital on 1/16/2022 with COVID-19 and gastrointestinal symptoms. Patient was discharged on 1/17/2022.
Red inflamed bump where injection was given, 104 fever loss of breathe  rash  cough  runny nose  body weakness
About 13 hours post-injection I developed a low-grade fever, chills, body aches, loss of appetite, exhaustion, difficulty concentrating, and difficulty sleeping. These have remained for two days.
She checked her sugar and it was very low, it took 4-5 days until blood sugar level was normal; It took 4-5 days until blood sugar level was normal; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE DECREASED (She checked her sugar and it was very low, it took 4-5 days until blood sugar level was normal) and BLOOD GLUCOSE ABNORMAL (It took 4-5 days until blood sugar level was normal) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetic. Concomitant products included LABETALOL, PREDNISONE, TACROLIMUS, METHIMAZOLE and CHLORTHALIDONE for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced BLOOD GLUCOSE DECREASED (She checked her sugar and it was very low, it took 4-5 days until blood sugar level was normal) and BLOOD GLUCOSE ABNORMAL (It took 4-5 days until blood sugar level was normal). On 12-Mar-2021, BLOOD GLUCOSE DECREASED (She checked her sugar and it was very low, it took 4-5 days until blood sugar level was normal) and BLOOD GLUCOSE ABNORMAL (It took 4-5 days until blood sugar level was normal) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication also included eye drops.
Within 6 minutes I had a metalic taste in my mouth, the roof of my mouth went numb, my tongue started to swell up, the inside of my mouth started to swell up. I lost sense of taste to even water. I was allowed to take my 50 mg of benedryl. My BP was 171/100.  I was taken to the ED and that is where I received the vaccine as well.
apnea episode on 8MAY95 for >15sec & was limp & pale during episode; pt required a few mouth-to-mouth puffs a/starting to breathe again;
pt recvd vax 12OCT93 & reported that evening exp sx including numbness to inner upper lip, itching to palate, sensation of pins & needles on tongue & fever to 101; took APAP;
This spontaneous report was received from a medical assistant concerning a 25 year old female patient with no pertinent medical history and no drug reactions or allergies. Approximately on an unknown date in 1998 (reported as at the age of 10 years old), the patient was vaccinated with dose 1 (Merck) VARIVAX (lot number, expiry date dose and route unspecified) at a clinic or hospital with funds since her was an employee and it was offered for children. There was no concomitant therapy. On an unknown date, the patient had a titer of not immune. The patient sought an unspecified medical attention. The outcome of titer of not immune was unknown. The relatedness for the event was unknown for (Merck) VARIVAX. Additional information has been requested.
Significant left subclavicular lymphadenopathy; single area measured 10 mm on ultrasound.
not able to raise their left hand to high; minor muscle issue; little hurt, when turning the light, on their left arm; This spontaneous case was reported by a consumer and describes the occurrence of MOVEMENT DISORDER (not able to raise their left hand to high), MUSCLE DISORDER (minor muscle issue) and PAIN IN EXTREMITY (little hurt, when turning the light, on their left arm) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031H21A, 030B21A and 045A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced MOVEMENT DISORDER (not able to raise their left hand to high), MUSCLE DISORDER (minor muscle issue) and PAIN IN EXTREMITY (little hurt, when turning the light, on their left arm). At the time of the report, MOVEMENT DISORDER (not able to raise their left hand to high), MUSCLE DISORDER (minor muscle issue) and PAIN IN EXTREMITY (little hurt, when turning the light, on their left arm) outcome was unknown.            No concomitant drug details were reported. No treatment details were reported.   This case was linked to MOD-2022-437569, MOD-2022-437875 (Patient Link).
Starting about 3 hours after receiving the vaccine, my arm became sore and I was very achy. I had a headache and severe muscle and joint aches. I could feel it "move through my system" and it felt like a severe flu. Also, I had severe pain in my head and felt like my body was being attacked. Any part of my body that was weak/previously injured was in extreme pain. These symptoms lasted for 3 days. I still felt very fatigued and still am to this day. A week after receiving the vaccine, I went to the doctor for blood work due to still feeling sick. Everything came back normal. She told me to see her before considering receiving another COVID shot due to my sensitivity to them. I started taking B vitamins but they aren't helping. I don't sleep well. I started getting canker sores in my mouth and I went to the dentist for it, but they are not sure what is causing them. So, they are referring me to an oral surgeon. Shortly after receiving the vaccine, my taste and smell came back with a heightened intensity to the point where I am unable to eat certain foods due to a chemical taste.
The first two days I had extreme soreness in my back and and muscles. The soreness & pain lessened considerably after two days.  However,  the aching muscles and joints  has not gone away completely. Over the past week, the pain is becoming more noticeable again and causing me to lose sleep and making it difficult to resume my normal exercise activities, which i did without any pain before the second vaccine. I now have to use anti-inflamatory over the counter medication for the pain.
Patient became ill approximately 2 weeks prior to ED presentation, reporting intermittent headache, nasal congestion, fatigue, nausea, and mild cough. Patient report nausea has been causing her inability to eat and drink. Patient also reports mobility challenges due to fatigue. Patient was found to be hyponatremic, hypomagnesemic, and hypokalemic. Patient will be admitted for management of these electrolyte imbalances. Patient is receiving replacement of magnesium, potassium, and sodium.
This spontaneous report as received from a medical assistant referring to a patient of unknown age and gender. The patient's concurrent conditions, medical histories and concomitant therapies were not reported. On 07-NOV-2016, the patient was vaccinated with an expired dose of RECOMBIVAX HB (lot # K021581 with expiration date 24-OCT-2016; dose and route were unknown. No adverse effect was reported. Additional information has been requested.
Symptoms started the day after the injection  with a headache, nausea, dizziness, malaise, fatigue, soreness at the injection site, and general flu like symptoms. Roughly one week after the shot my right hand felt tingly, similar to when a limb "falls asleep" this feeling slowly made its way up my right arm, then crossed to the left arm with the tingling starting from the shoulder then working its way down. Cognitive dysfunction, relentless lingering headache.
Mom states that the pt has a history of having a localized reaction to the flu shot in the past. He did have his flu shot done on 10/26 and he seems to be having a similar reaction to what he has had in the past. She states that there is a red, swollen, hot to the touch area about 5 inches in diameter surrounding his injection site. She states that she has noticed almost a blistering at the injection site before which she has not seen happen in the past. She has been giving benadryl which has helped to bring the swelling down and the pt isn't really bothered by the reaction but she did want to let the providers know.
spillane-Parsonage-Turner synd w/brachial plexopathy;pt states onset was DEC97 & gradual lt arm weakness;
she also got really sick; Lost her taste and smell; Lost her taste and smell; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "she also got really sick"; ANOSMIA (non-serious), AGEUSIA (non-serious), outcome "unknown" and all described as "Lost her taste and smell".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
My period began five days early. It is very regular, so early or late never happens. I had increased PMS symptoms, and the menstrual flow is very very heavy and bright red ? the heaviest flow I have experienced and the brightest red blood I have experienced. It shows no signs of diminishing, though in a normal cycle, I would be nearly done.
beginning at approx. 11:30 a.m. left arm, hands, and fingers went numb with marked weakness; followed by left side of face (cheek) numbness/feeling of fullness (similar to the feeling after a nonvaccine shot from dentist); numbness/feeling of fullness traveled to upper cheekbone under left eye; left eye vision was bothered, had to keep blinking to see correctly; throat then became extremely sore and dry; left sinus became blocked. These symptoms were over the course of 2 hours following the shot and subsided significantly by 2:30 p.m. (3/17/21)--- the start time of onset of symptoms is my best estimate.
Patient presented to the ER via EMS due to Covid-like symptoms. Patient has advanced dementia and is minimally verbal at baseline; daughter reports is able to ambulate independently at baseline though. Daughter, who is  States that patient starting not acting herself yesterday and started to developed fever, chills, congestion.  States that her oxygen level was getting into the 80s so she decided to call EMS. Upon EMS arrival oxygen saturation was 94%.  While in the ED initial BP 84/45, HR 107, RR 20, otherwise VSS. EKG showing sinus tachycardia, rate 115. Labs revealing WBC 1.4, glucose 108, BUN/Cr 27/1.8 with GFR 25, lactic acid 3.41 -- > 4.49. Procal 49.85, troponin 0.033 -- > 0.064. BNP 371. UA positive for UTI. Blood cultures obtained. Flu negative. COVID swab +. CT head and CXR negative. Received 1L bolus, cefepime, ofirmev. Patients blood pressure intially improved and then decreased into the 70s systolic and additional 1L bolus ordered. Patient diagnosed with septic shock secondary to acute pyelonephritis versus covid-19. Patient diagnosed with acute respiratory failure due to covid-19. Patient required supplemental oxygen, antibiotics and IV steroids.
A consumer report has been received. The report concerns a patient of unknown gender, who received Nasal FLUMIST QUADRILAVENT, 0.2 Millilitres, Unknown. FLUMIST QUADRIVALENT started on 26-Dec-2015. The patient experienced high fever and vomiting. The outcome of the event of high fever and vomiting was unknown. The report was considered to be non-serious.
shingles outbreak; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 73-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In September 2018, the patient received the 1st dose of Shingrix (intramuscular). In February 2019, less than a year after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient's friend. The age at vaccination was not reported, but the patient was 73 years old at the time of reporting. The patient experienced shingles outbreak. No further details were available. It was reported that the the patient would encourage her friend to contact Glaxosmithkline (GSK) to provide more details regarding the report.
This spontaneous report was received from a healthcare worker and refers to unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical history provided. On unknown dates, the patients were vaccinated with improperly stored doses of oral ROTATEQ (lot # L013202, expiration date 27-JAN-2017, exact dose was not reported, orally). No adverse effects were reported. The administered doses experienced a temperature excursion of 10 degrees Celsius for 1 hour and 16 minutes. The temperature excursion was detected by a data logger. There was no previous excursions. Additional information has been requested.
Extra dose given/9 month old patient accidentally received a 4th dose of Infanrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too short in a male patient who received DTPa (Infanrix) (batch number 9R2D7, expiry date 23-MAY-2025) for prophylaxis.   Previously administered products included Infanrix (received three doses of Infanrix on an unknown date).   On an unknown date, the patient received the 4th dose of Infanrix. On an unknown date, an unknown time after receiving Infanrix, the patient experienced drug dose administration interval too short (Verbatim: Extra dose given/9 month old patient accidentally received a 4th dose of Infanrix ). The outcome of the drug dose administration interval too short was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 1-June-2023 A nurse wished to know if there was any information that could be given.  The partial information about the  patient, vaccine and event were given. The reporter consented to follow-up. The patient received 4th dose of Infanrix earlier than the recommended interval, which led to shortening of vaccine schedule.
Patient was given full dose (0.5ml) after receiving one dose of Johnson and Johnson prior. Patient should have received booster dose (0.25ml) instead.
I am a surgical resident who had covid in November. Date of my symptom onset was 11/13/20. My positive test was on 11/14/20. I was moderately ill with covid, but did not require hospitalization. I was offered a vaccine and accepted on 12/28/20. I got the modern vaccine.  On 12/29 AM I developed significant symptoms. I was so exhausted and sore I was barely able to complete my cases for the day. I only had a temp max of 99.7, but I felt worse the I did when I had covid (except for the respiratory symptoms). I came home by noon in 12/29 and took Motrin then went to sleep by 1400. As soon as I woke up on 12/30 I took aleve 400 mg and felt well enough to work the next day. Symptoms improved progressively in the subsequent days.